期刊文献+

ADROIT指引导管在对冠状动脉分叉病变行经皮冠状动脉介入治疗中的应用 被引量:3

Application of ADROIT guide catheter in the coronary bifurcation lesion intervention
下载PDF
导出
摘要 目的探讨ADROIT指引导管在对冠状动脉分叉病变行经皮冠状动脉介入治疗(PCI中应用的临床效果。方法纳入2015年9月至2017年9月就诊于江门市中心医院心内科需行PCI的分叉病变患者共120例,按照简单随机数字表法分为试验组(ADROIT指引导管组)60例和对照组(普通指引导管组)60例,比较两组患者手术时间、X线曝光时间(简称"曝光时间")、对比剂用量、手术成功率以及术后6个月支架内再狭窄发生率等。结果试验组患者总手术时间少于对照组[(49.2±19.5)min比(63.4±21.5)min,P<0.001],而曝光时间(双支架)高于对照组[(37.0±11.6)min比(29.3±5.9)min,P=0.037],差异均有统计学意义。两组患者均未发生明显夹层,手术成功率及支架内再狭窄发生率比较,差异均无统计学意义(均P>0.05)。单支架技术JWT患者手术时间、曝光时间及对比剂用量比较,差异均无统计学意义(均P>0.05)。结论 ADROIT指引导管在冠状动脉分叉病变行PCI中较普通指引导管手术时间更少,术中并发症发生率及术后中期效果与普通指引导管差异不大,能完成大部分分叉病变的治疗,值得临床推广。 Objective To compare the clinical effect between ADROIT and regular guide catheters in coronary bifurcation lesion intervention.Methods A total of 120 patients with bifurcation lesions were treated by coronary intervention therapy in the cardiology department of Jiangmen Central Hospital from September,2015 to September,2017.The patients were divided into two groups with simple random number table method,60 in the experimental group(ADROIT guide catheter)and 60 in the control group.Patients in the two groups were compared on procedural time,fluoroscopy time,contrast volume,replacement of AL strong support guide catheter and incidence of stent restenosis at six months.Results The procedural time in the experimental group was shorter than that in the contrast group[(49.2±19.5)min vs.(63.4±21.5)min,P<0.001],and the fluoroscopy time(double stents)was longer than that in the contrast group[(37.0±11.6)min vs.(29.3±5.9)min,P=0.037],both were signifi cant in statistics.There was no coronary artery dissection in both groups,and there was no signifi cant diff erence in success rate and restenosis rate between the experimental and control group(all P>0.05).There was no signifi cant diff erence in procedure time,fluoroscopy time or contrast volume between two groups in the JWT subgroup analysis(all P>0.05).Conclusions Compared with the regular guide catheter,ADROIT guide catheter could reduce the procedural time,with no diff erence on the incident rate of complications and mid-term eff ect.It can help with most of the bifurcation lesions treatment.It is safe and worth a promotion in clinical use.
作者 赖浚兴 谭文锋 宋岸坚 张斌 LAI Jun-xing;TAN Wen-feng;SONG An-jian;ZHANG Bin(Department of Cardiology,Jiangmen Central Hospital,Jiangmen529000,China)
出处 《中国介入心脏病学杂志》 2019年第3期162-166,共5页 Chinese Journal of Interventional Cardiology
关键词 指引导管 分叉病变 经皮冠状动脉介入治疗 Guide catheter Bifurcation lesions Percutaneous coronary intervention
  • 相关文献

参考文献2

二级参考文献17

  • 1Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ( EACTS ), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J,2010 , 31:2501-2555. 被引量:1
  • 2Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation, 2011, 124 :e574-651. 被引量:1
  • 3Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coil Cardiol, 2011,58 :e123-210. 被引量:1
  • 4Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation ( EuroSCORE ). Eur J Cardiothorac Surg, 1999,16:9-13. 被引量:1
  • 5Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009,360:961- 972. 被引量:1
  • 6Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coil Cardiol,2010,55:1923-1932. 被引量:1
  • 7Online STS fish calculator [ S/OL]. [ 2012-01-01 ]. http:// riskcalc, sts. org/STSWebRiskCalc273/de, aspx. 被引量:1
  • 8Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial. Lancet,2010,376 : 1233-1243. 被引量:1
  • 9Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Cell Cardiol,2007,50 : 1742-1751. 被引量:1
  • 10Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation, 2011,123:2736-2747. 被引量:1

共引文献425

同被引文献28

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部